The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports
Open accessAbstract
OBJECTIVE: Adverse drug events (ADEs) are common and account for 770 000 injuries and deaths each year and drug interactions account for as much as 30% of these ADEs. Spontaneous reporting systems routinely collect ADEs from patients on complex combinations of medications and provide an opportunity to discover unexpected drug interactions. Unfortunately, current algorithms for such "signal detection" are limited by underreporting of interactions that are not expected. We present a novel method to identify latent drug interaction signals in the case of underreporting. MATERIALS AND METHODS: We identified eight clinically significant adverse events. We used the FDA's Adverse Event Reporting System to build profiles for these adverse events based on the side effects of drugs known to produce them. We then looked for pairs of drugs that match these single-drug profiles in order to predict potential interactions. We evaluated these interactions in two independent data sets and also through a retrospective analysis of the Stanford Hospital electronic medical records. RESULTS: We identified 171 novel drug interactions (for eight adverse event categories) that are significantly enriched for known drug interactions (p=0.0009) and used the electronic medical record for independently testing drug interaction hypotheses using multivariate statistical models with covariates. CONCLUSION: Our method provides an option for detecting hidden interactions in spontaneous reporting systems by using side effect profiles to infer the presence of unreported adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Together, these watchdogs continue to participate in consequential studies to analyze the biased outcomes of models used in domains as varied as content curation [80], online advertising [40], tenant screening [39,70], child welfare [12], criminal justice [5,10,20,26,78], hiring [63], immigration [24], education [25] or public health [15,56].”
From Outsider Oversight: Designing a Third Party Audit Ecosystem for AI Governance (2022) · cites this paper as [80]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
STITCH: interaction networks of chemicals and proteins
Kuhn, M., von Mering, C., Campillos, M., Jensen, L. J., & Bork, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm795 · Cited by 998
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
NEUVONEN, P., NIEMI, M., & BACKMAN, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.003 · Cited by 859
Grapefruit juice–drug interactions
Bailey, D. G., Malcolm, J., Arnold, O., & David Spence, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00764.x · Cited by 740
Empirical bayes screening for multi-item associations
DuMouchel, W., & Pregibon, D. (2001) · Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/502512.502526 · Cited by 266
Cited by
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Artificial Intelligence for Drug Toxicity and Safety
Basile, A. O., Yahi, A., & Tatonetti, N. P. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.005 · Cited by 363
Self-citationAI in Health: State of the Art, Challenges, and Future Directions
Wang, F., & Preininger, A. (2019) · Yearbook of Medical Informatics · doi:10.1055/s-0039-1677908 · Cited by 398
“[93] developed a signal detection algorithm for the identification of novel drug-drug interactions using FAERS.”
MethodCheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
“Equation 3 has been corrected.”
Zhang, W., Chen, Y., Liu, F., Luo, F., Tian, G., & Li, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1415-9 · Cited by 356
Metadata
- Authors
- Tatonetti, N. P., Fernald, G. H., & Altman, R. B.
- Affiliations
- Stanford University (US)
- Corresponding author
- Altman, Russ B
- Venue
- Journal of the American Medical Informatics Association
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01
- Volume
- 19
- Issue
- 1
- Pages
- 79-85
- ISSN
- 1067-5027 (ISSN-L)
- 1527-974X
- PMC
- PMC3240755
- OpenAlex
- W2117397379
- Cited by
- 203
- References
- 24
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 18 · 2023: 10 · 2022: 14 · 2021: 14 · 2020: 18 · 2019: 13 · 2018: 11 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 15 · 2013: 21 · 2012: 6
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of the American Medical Informatics Association (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM102365, R24GM061374, R24-GM61374)
- U.S. National Library of Medicine (LM05652, LM007033, R01LM005652, T15LM007033)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Data-Driven Disease Surveillance
- Keywords
- drug-drug interactions, adverse drug reactions, signal detection, spontaneous adverse event reporting, underreporting, side effect profile, FDA Adverse Event Reporting System, electronic health records, drug interaction prediction, pharmacovigilance
- MeSH terms
- Algorithms, Drug Interactions, False Positive Reactions, Humans, ROC Curve, United States, United States Food and Drug Administration, Logistic Models, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. https://app.cochat.ai/papers/10.1136/amiajnl-2011-000214
- The paper
- Tatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012). A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. Journal of the American Medical Informatics Association. https://doi.org/10.1136/amiajnl-2011-000214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.